APLS vs MSI · rev $781.4M vs P/E 33, rev $5.85B
Apellis Pharmaceuticals Inc (APLS) versus Motorola Solutions Inc (MSI) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Motorola Solutions Inc (MSI) is a communication equipment company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported MSI revenue for 2026-07-04 was $5.85B. Net income was $923.0M. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
APLS currently screens at market cap $2.29B. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
Not investment advice. Open the APLS and MSI stock pages for the full models.
Not investment advice.